A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : Lung can cer is usu ally pre ce ded by ano re xi a, fre qu ently le a ding to weight loss and cac he xi a. Ant hro po met ric me a su re ments are used to eva lu a te nut ri ti o nal sta tes. In this study, it was ai med to re ve al the prog nos tic va lu es of ant hro po met ric me a su re ments and bioc he mi cal pa ra me ters in ad van ced non-small cell lung car ci no mas (NSCLC). M Ma at te er ri ia al l a an nd d M Me et t --h ho od ds s: : Pa ti ents his to pat ho lo gi cally di ag no sed as ad van ced sta ge NSCLC bet we en De cem ber 2004 and Ju ne 2006 we re inc lu ded in the study. Pa ti ents who had un der go ne sur gi cal re sec ti on were exc lu ded. Fo ur ant hro po met ric, thre e bi oc he mi cal me a su re ments and the nut ri ti o nal in dex of pa ti ents we re re cor ded be fo re any tre at ment. R Re e s su ul lt ts s: : A to tal of 69 ma le pa ti ents, with a mean age of 58.8 ye ars, were fol lo wed for 12.98 months on ave ra ge. Forty-ni ne (71%) pa ti ents were at sta ge II IB, whe re as 20 (29%) pa ti ents we re at sta ge IV. The me an sur vi val pe ri od was 12.0 months. Low le vels of se rum al bu min (p< 0.001) and pre al bu min (p= 0.002), body mass in dex (p= 0.000), skin thick ness of tri ceps (p< 0.001), and up per arm cir cum fe ren ce (p< 0.001), as well as high le vels of nut ri ti o nal in dex (p< 0.001) we re de ter mi ned as po or prog nos tic fac tors. The re was no re la ti on bet we en se rum trans fer rin and sur vi val (p= 0.229). C Co on nc c l lu u s si i o on n: : Lo wer se rum al bumin, pre al bu min, body mass in dex, tri ceps skin thick ness, up per arm cir cum fe ren ce and hig her nut ri ti o nal in dex may ref lect shor ter sur vi val in ad van ced NSCLC despite go od per for man ce sta tus.
ung can cer is pre ce ded by ano re xi a which fre qu ently le ads to we ight loss and so me times cac he xi a. Ant hro po met ric me a su rements -body we ight (BW), per cent ide al we ight (PIW), body mass in dex (BMI), tri ceps skin thickness (TST), up per arm cir cum fe ren ce (UAC) and bi oc he mi cal pa ra me ters are used to eva lu a te the nut ri ti o nal sta te. [1] [2] [3] [4] [5] Body mass index (BMI) [(we ight (kg)/squ a re me ter he ight (m2)] be low 15 in di ca tes se ve re nutri ti o nal di sor der, whe re as [15] [16] [17] [18] [19] in di ca te low weight, 20-25 in di ca tes nor mal we ight, 26-30 in di ca tes gra de-1 obe sity, 31-40 in di ca tes gra de-2 obe sity and the va lu es over 41 in di ca tes gra de-3 obe sity. 5 Tri ceps skin thick ness and sub cu ta ne o us adipo se tis su e thick ness are in dices for body fat sto re, and me a su re ments be low 10 mi li me ter (mm) in men and 13 mm in wo men in di ca te mal nut ri ti on. Up per arm cir cum fe ren ce is a me a su re ment for both mus cu lar and adi po se tis su e and it eva lu a tes mus cu lar tis su e and skin thick ness to get her. Le vels be low 20 cm in men and 18 cm in wo men are consi de red pat ho lo gi cal. [3] [4] [5] Se rum al bu min is used as an in di ca tor for visce ral pro te in dep le ti on and it dec re a ses in long term mal nut ri ti on. Ha ving a half-li fe of ap pro xima tely 20 days, al bu min is a we ak in di ca tor for early pro te in mal nut ri ti on. Le vels be low 2.1 g/dl re ve al se ve re dep le ti on, whe re as 2.1-2.7 g/dl re veals mo de ra te dep le ti on and 2.8-3.5 g/dl re ve als mild dep le ti on. [3] [4] [5] Se rum pre al bu min, with a half-li fe of two days and be ing ra pidly synthe si zed and deg ra ded, is a mo re sen si ti ve and re li ab le pa ra me ter in di cating mal nut ri ti on. The va lu e of 15-10 mg/dl in dica tes mild, 10-5 mg/dl in di ca tes mo de ra te and be low 5 mg/dl in di ca tes se ve re pro te in dep le tion. [3] [4] [5] Se rum trans fer rin, a be ta glo bu lin, ref lects the acu te al te ra ti ons in vis ce ral pro te in mo re ra pidly than se rum al bu min, sin ce it has a half-li fe of 8-10 days. Va lu es be low 212 mg/dl in di ca te pro te in defi ci ency. Se rum trans fer rin le vels (me a su red by radi al im mu no dif fu si on met hod) bet we en 150-200 mg/dl in di ca te mild vis ce ral dep le ti on, 100-150 mg/dl in di ca tes mo de ra te vis ce ral dep le ti on, and be low 100 mg/dl in di ca tes se ve re dep le ti on. [3] [4] [5] The sta ge and the per for man ce sta tus are the ma in prog nos tic fac tors in non-small cell lung cancer (NSCLC), whi le gen der, we ight loss, lac ta te dehy dro ge na se, al bu min, h e mog lo bin, throm bocy tes and le u cocy te we re al so re por ted as prognostic factors. Be si des la bo ra tory pa ra me ters, so me simp le mea su re ments of ant hro po met ric struc tu re are tho ught to ref lect the prog no sis in ad van ced NSCLC. The aim of this study is to disp lay whet her the ini ti al va lu es of se rum al bu min, pre al bu min, trans fer rin, ant hropo met ric me a su re ments and a ra rely stu di ed pa rame ter, nut ri ti o nal in dex, co uld be used to get her to es ti ma te sur vi val in NSCLC.
MA TE RI AL AND MET HODS

PA TI ENTS
Pa ti ents who we re his to pat ho lo gi cally di ag no sed as NSCLC eit her in the in pa ti ent or the out pa ti ent cli nic of Iz mir Tra i ning and Re se arch Hos pi tal for Tho ra cic Me di ci ne and Sur gery, Iz mir, Tur key, bet we en De cem ber 2004 and Ju ne 2006, with cli ni cal sta ge II I-B or sta ge IV, 6 go od per for man ce sta tus (Eas tern Co o pe ra ti ve On co logy Gro up [ECOG] 0-2) and wit ho ut any tre at ment (ne it her che mot herapy nor ra di ot he rapy) we re inc lu ded in the pre sent pros pec ti ve study.
Pa ti ents we re re fer red to the ir che mot he rapy and/or ra di ot he rapy (RT) tre at ments af ter the mea su re ments re qu i red for the study were performed. The res pon se was eva lu a ted vi a com pu te ri zed tomog raphy (CT) of the tho rax in pa ti ents who had be en tre a ted with two co ur ses of che mot he rapy. The che mot he rapy do ses of stab le or in-reg res si on pa ti ents we re comp le ted af ter 4 or 6 co ur ses. Pa tients who had un der go ne sur gi cal re sec ti on af ter che mot he rapy and/or RT we re exc lu ded. ME A SU RE MENTS Fo ur ant hro po met ric me a su re ments we re per for med on the pa ti ents: body we ight (kg), he ight (cm), TST (cm) and UAC (cm). TST was me a su red vi a a ca li per at the mid po int of the dis tan ce bet we en olec ra non and ac ro mi on of the non-do mi nant arm for the deter mi na ti on of the sub cu ta ne o us adi po se tis su e. UAC Turkiye Klinikleri J Med Sci 2010;30 (4) was me a su red at mid po int of the dis tan ce bet we en olec ra non and ac ro mi on by a ta pe li ne. 5 The va lu es de fi ned by Na ti o nal He alth and Nut ri ti on Exa mi nati on Sur vey we re used as the re fe ren ce. 7 BMI [we ight/he ight 2 ] and PIW (for men) [50 kg + every inch abo ve 5 fe et ×1.9] we re cal cu la ted. 8 Age, gen der, per for man ce sta tus, his to logy, 9 sta ge of tu mor, 6 se rum al bu min, pre al bu min, trans fer rin, lymphocy te le vels, drugs used for chemot he rapy, num ber of che mot he rapy co ur ses, radi ot he rapy app li ca ti ons, sur vi val and li fe ti me da ta we re re cor ded.
The blo od samp les of the pa ti ents we re kept in tu bes con ta i ning K3 ED TA for comp le te blo od count, and in tu bes con ta i ning no ad di ti ves for bi oche mi cal pa ra me ters. The comp le te blo od co unt was analy zed by au to ma ti zed Co ul ter Gen-S (Beck man Co ul ter, USA) equ ip ment. In or der to per form albu min, pre al bu min and trans fer ring me a su rements, se rum samp les of pa ti ents we re se pa ra ted by cen tri fu ging blo od samp les at 5000 rpm for three mi nu tes. Trans fer rin and pre al bu min we re me a sured qu an ti ta ti vely vi a au to ma ti zed Ar ray 360 nephe lo metry (Beck man Co ul ter, USA) equ ip ment by using ori gi nal kits of the sa me com pany. Al bu min was me a su red by co lo ri met ric met hod vi a Oly mpus AU2700 equ ip ment, by using ori gi nal kits of the same com pany. The me an va lu es we re ac cep ted as 18-45 mg/dl for pre al bu min, 212-360 mg/dl for trans fer rin, and 3.5-5 g/dl for al bu min.
The "gro up with mal nut ri ti o n" inc lu ded tho se with a nut ri ti o nal in dex (NI) abo ve or equ al to 0.5, and the "gro up wit ho ut mal nut ri ti o n" inc lu ded tho se with a NI be low 0.5: PALB: Se rum pre al bu min con cen tra ti on (g/dl) TLC: To tal lymphocy te co unt (10 9 /L) PIW: [(pre sent we ight/ ide al we ight) × 100)] STA TIS TI CAL ANALY SIS SPSS-13 com pu ter soft wa re was used for sta tis ti cal analy ses. Da ta we re analy zed by using Cox-reg ressi on analy sis and Kap lan-Me i er sur vi val func ti on analy sis. Kap lan-Me i er sur vi val func ti on analy sis, Log Rank Test was used for the com pa ri son of the gro ups. Dif fe ren ces we re as su med to be sig ni fi cant when p< 0.05.
The study was ap pro ved by the et hics com mitte e. Iin for med con sents were obtained from all pati ents.
RE SULTS
A to tal of 77 ino pe rab le pa ti ents with the sta ge of eit her II IB or IV NSCLC and ECOG 0-2 we re inclu ded in the study. A to tal of eight pa ti ents who had un der go ne sur gi cal re sec ti on af ter in duc ti on (che mot he rapy and/or RT) we re exc lu ded. The mean age of the re ma i ning 69 pa ti ents was 58.8 ± 9.1 (34-77) ye ars. All the par ti ci pants we re ma les. Forty-ni ne (71%) pa ti ents we re at sta ge II IB, where as 20 (29%) pa ti ents we re at sta ge IV. The his tolo gic types are disp la yed in Tab le 1.
Che mot he rapy was per for med in 61 (88.4%) pa ti ents, ra di cal RT was per for med in 30 (43.5%), and pal li a ti ve RT was per for med in 15 (21.7%) the pa ti ents. The drugs used in che mot he rapy are presen ted in Tab les 2 and 3. Se rum pa ra me ters and ant hro po met ric me a su re ments of the pa ti ents are shown in Tab The me an fol low-up du ra ti on of the pa ti ents was 12.98 months, with a me an sur vi val pe ri od of 12.0 ± 1.55 (1-36.5) months (Fi gu re 1).
Ove rall sur vi val of the pa ti ents who se se rum al bu min and pre al bu min le vels be low the thres hold we re fo und sig ni fi cantly shor ter (Kap lan-Mei er sur vi val func ti on analy sis Log Rank test, p< 0.001 and p= 0.002) (Fi gu res 2 and 3). Ho we ver, the re was no cor re la ti on bet we en trans fer rin level and sur vi val (p= 0.229) (Fi gu re 4). The sur vivals of pa ti ents with lo wer TST and UAC we re sta tis ti cally shor ter (p< 0.001 and p< 0.001) (Fi gu res 5 and 6). Pa ti ents with a NI abo ve or equ al to 0.5, as well as the pa ti ents with a BMI be low 20, we re fo und to ha ve a sig ni fi cantly shor ter sur vival (p< 0.001 and p< 0.001) (Tab le 5) (Fi gu res 7 and 8).
In Cox-reg res si on analy sis, the re we re po si tive cor re la ti ons bet we en sur vi val duaration and serum al bu min le vels (p= 0.001), pre al bu min le vels (p= 0.001) and BMI (p= 0.005). Ho we ver, a ne ga tive cor re la ti on was de ter mi ned bet we en sur vi val duration and NI (p< 0.001). No net he less, no cor rela ti on was fo und bet we en sur vi val duration and serum trans fer rin le vels (p= 0.262), TST (p= 0.424) and UAC (p= 0.957).
DIS CUS SI ON
Lo wer se rum al bu min, pre al bu min, BMI, TST and UAC, and high NI in pa ti ents with ad van ced NSCLC are re la ted with short sur vi val.
The performance status, weight loss and stage of disease in NSCLC patients were reported as the most important prognostic factors, whereas serum lactate dehydrogenase and albumin levels, as well as sex, age, histological properties and biological factors, were reported as potential prognostic factors. 11 Mal nut ri ti on and we ight loss are fre qu ently en co un te red at the ti me of di ag no sis in can cer pati ents and is as so ci a ted with ad van ced disease. Pati ent's we ight is al so in suf fi ci ent to in di ca te the nut ri ti o nal sta te and to ref lect the al te ra ti ons in ca lo ry in ta ke du e to tre at ment or the di se a se. 12 Pati ents with mal nut ri ti on ha ve a lon ger hos pi ta liza ti on pe ri od, 13 a lo wer qu a lity of li fe, 14 and lo wer sur vi val pe ri od 15 com pa red to well no u ris hed pati ents. The in ci den ce of mal nut ri ti on du ring advan ced sta ges of lung can cer is 90%. [16] [17] [18] In a study inc lu ding 5000 pa ti ents with inope rab le NSCLC, non-ana to mi cal fac tors such as per for man ce sta tus of the pa ti ents, sta ge of the dise a se and we ight loss we re de ter mi ned as the most re le vant prog nos tic fac tors, 19 whi le in anot her study inc lu ding 651 pa ti ents, pre sen ce of symptoms, per for man ce sta tus, we ight loss and age were stres sed as the most im por tant prog nos tic fac tors. 20 La i and Perg eva lu a ted ant hro po met ric me asu re ments (we ight-he ight ra ti o, TST and UAC) and bi oc he mi cal pa ra me ters (al bu min, trans fer rin, to tal lymphocy te co unt and cre a ti nin-he ight index) in 150 newly di ag no sed pa ti ents with lung car ci no ma. 21 The ab nor ma lity per cent of nut ri ti onal pa ra me ters was bet we en 15-31%, and at le ast one ab nor mal pa ra me ter was ob ser ved in most (59%) of the pa ti ents. As the num ber of ab nor mal nut ri ti o nal pa ra me ters in cre a sed, the sur vi val peri od dec re a sed. Both ant hro po met ric and bi oc hemi cal nut ri ti o nal pa ra me ters we re re li ab le in di ca tors in eva lu a ting the per for man ce sta tus and sur vi val of the pa ti ents with lung car ci no ma. 21 We as ses sed la bo ra tory and ant hro po met ric me asu re ments to get her to analy ze the ir ro les as prognos tic fac tors. Lo wer se rum al bu min and pre al bu min, lo wer BMI, TST and UAC, and higher nut ri ti o nal in dex we re re la ted to po or sur vival in ad van ced NSCLC.
When the seven nut ri ti o nal sta tus va ri ab les (TST, UAC, hol ding po wer, he mog lo bin le vels, prote in and al bu min) we re analy zed in 15 lung can cer pa ti ents who we re tre a ted by cisp la tin, TST was deter mi ned as the most sen si ti ve in di ca tor for the nut ri ti o nal sta tus du ring the che mot he rapy. It was re por ted that pe ri o di cal eva lu a ti on of nut ri ti o nal status was be ne fi ci al du ring the che mot he rapy pro tocol, and hand ling na u se a, vo mi ting and an xi ety as well as pro tec ti on from in fec ti ons and con ti nu ing ade qu a te nut ri ti on were equ ally im por tant. 22 In a study in which eight cli ni cal va ri ab les (age, sex, per for man ce sta tus, type of tu mor cell, cli ni cal sta ge, TNM fac tors), five ant hro po met ric me a su re ments (we ight, he ight, TST, UAC, wrist cir cum fe ren ce), and la bo ra tory tests (se rum to tal pro te in, al bu min, trans fer rin, hap tog lo bin, cal cium, cre a ti nin, phosp ho rus, iron) of 388 pa ti ents with lung car ci no ma we re eva lu a ted, TST and UAC we re fo und to be sig ni fi cantly cor re la ted with the sur vi val duration, whe re as the cor re la ti on bet we en wrist cir cum fe ren ce and sur vi val duration was not sig ni fi cant. Se rum iron, al bu min, trans fer rin and hap tog lo bin we re fo und to be strong in di ca tors of sur vi val duration, and prog nos tic fac tors we re listed ac cor ding to the ir im por tan ce as sta ge of the dise a se, per for man ce sta tus, hap tog lo bin and al bu min le vels. 7 In the pre sent study, in re cently di ag no sed high sta ge NSCLC pa ti ents, it was de ter mi ned that the ove rall sur vi val of pa ti ents with lo wer TST, UAC and BMI was shor ter com pa red to pa ti ents in whom low va lu es we re not ob ser ved. Shor ter mean sur vi val pe ri od was al so de ter mi ned in pa ti ents with a NI abo ve 0.5 when com pa red to the ones with a NI be low 0.5. The re was no re la ti on bet ween se rum trans fer rin va lu e and sur vi val.
Se rum al bu min con cen tra ti on was fo und to be re la ted to the prog no sis in 13 of 14 stu di es re garding NSCLC and small cell lung car ci no ma. 7 No cor re la ti on was fo und bet we en sur vi val pe ri od and pre al bu min, eva lu a ted to get her with la bo ra tory tests such as fer ri tin, C-re ac ti ve pro te in, be ta-2 mic rog lo bu lin, in both uni va ri a te and mul ti va ri a te analy ses. 23 Many stu di es ha ve shown that pre al bu min con cen tra ti on is a sen si ti ve and cost ef fec ti ve method in de tec ting the se ve rity of mal nut ri ti on in pati ents with eit her se ri o us or chro nic di se a ses, as well as in can cer pa ti ents. [24] [25] [26] In the lat ter, pre albu min me a su re ment is a test that can disc lo se prote in-energy mal nut ri ti on. In the pre sent study, se rum al bu min and pre al bu min we re fo und to be cor re la ted with lo wer sur vi val pe ri ods, be ing factors for po or prog no sis. Ho we ver, cor re la ti on was not shown bet we en se rum trans fer rin le vels and sur vi val pe ri od.
NSCLC are he te ro ge ne o us gro ups, and the impor tan ce of the ir his to lo gi cal sub gro ups as prog nostic fac tors is still con tro ver si al. 19, 27 In the pre sent study, the his to lo gi cal sub gro ups we re not eva lu ated sin ce the num ber of the sub jects was li mi ted, and the dif fe ren ti a ti on of sub gro ups was ina de qua te in par ti cu lar ca ses.
We ight loss, BMI, TST and UAC are the ma in pa ra me ters pri ma rily analy zed in NSCLC to pre dict the prog no sis. This study analyzed anot her nut ri tio nal pa ra me ter, nut ri ti o nal in dex, and de tected a re la ti on bet we en hig her nut ri ti o nal in dex and survi val.
Lo wer se rum al bu min and pre al bu min, lo wer body mass in dex, tri ceps skin thick ness and up per arm cir cum fe ren ce, and hig her nut ri ti o nal in dex may ref lect a po or sur vi val in ad van ced NSCLC pati ents, even in tho se with a go od per for man ce status.
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